AU2002361654A8 - Mbcats as modifiers of the beta-catenin pathway and methods of use - Google Patents
Mbcats as modifiers of the beta-catenin pathway and methods of useInfo
- Publication number
- AU2002361654A8 AU2002361654A8 AU2002361654A AU2002361654A AU2002361654A8 AU 2002361654 A8 AU2002361654 A8 AU 2002361654A8 AU 2002361654 A AU2002361654 A AU 2002361654A AU 2002361654 A AU2002361654 A AU 2002361654A AU 2002361654 A8 AU2002361654 A8 AU 2002361654A8
- Authority
- AU
- Australia
- Prior art keywords
- mbcats
- modifiers
- beta
- methods
- catenin pathway
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34032201P | 2001-12-13 | 2001-12-13 | |
US34021301P | 2001-12-13 | 2001-12-13 | |
US34031401P | 2001-12-13 | 2001-12-13 | |
US60/340,322 | 2001-12-13 | ||
US60/340,213 | 2001-12-13 | ||
US60/340,314 | 2001-12-13 | ||
US35750202P | 2002-02-15 | 2002-02-15 | |
US60/357,502 | 2002-02-15 | ||
PCT/US2002/039796 WO2003052068A2 (en) | 2001-12-13 | 2002-12-12 | Mbcats as modifiers of the beta-catenin pathway and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002361654A8 true AU2002361654A8 (en) | 2003-06-30 |
AU2002361654A1 AU2002361654A1 (en) | 2003-06-30 |
Family
ID=27502619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002361654A Abandoned AU2002361654A1 (en) | 2001-12-13 | 2002-12-12 | Mbcats as modifiers of the beta-catenin pathway and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002361654A1 (en) |
WO (1) | WO2003052068A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE482979T1 (en) * | 2003-08-14 | 2010-10-15 | Exelixis Inc | UPS AS BETA-CATENIN PATHWAY MODIFYING SUBSTANCES AND METHODS OF APPLICATION |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5851775A (en) * | 1997-03-20 | 1998-12-22 | Johns Hopkins University | β-catenin, Tcf-4, and APC interact to prevent cancer |
US6303576B1 (en) * | 1999-04-21 | 2001-10-16 | Adherex Technologies Inc. | Compounds and methods for modulating β-catenin mediated gene expression |
-
2002
- 2002-12-12 AU AU2002361654A patent/AU2002361654A1/en not_active Abandoned
- 2002-12-12 WO PCT/US2002/039796 patent/WO2003052068A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002361654A1 (en) | 2003-06-30 |
WO2003052068A2 (en) | 2003-06-26 |
WO2003052068A3 (en) | 2003-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1401475A4 (en) | Prmts as modifiers of the p53 pathway and methods of use | |
AU2003224638A8 (en) | Pdpk1s as modifiers of the p53 pathway and methods of use | |
EP1421384A4 (en) | Hprp4s as modifiers of the p53 pathway and methods of use | |
PL375691A1 (en) | Imidazolopyridines and methods of making and using the same | |
EP1402051A4 (en) | Lces as modifiers of the p53 pathway and methods of use | |
EP1535067A4 (en) | PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE | |
AU2003295881A8 (en) | Lamps as modifiers of the p53 pathway and methods of use | |
AU2002361654A8 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003299990A8 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003217851A8 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003303094A8 (en) | Mat2as as modifiers of the p53 pathway and methods of use | |
AU2003274911A8 (en) | Mrbs as modifiers of the rb pathway and methods of use | |
AU2003213662A8 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003295928A8 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003294499A8 (en) | Rhebs as modifiers of the rb pathway and methods of use | |
EP1578945A3 (en) | Cct6s as modifiers of the rb pathway and methods of use | |
AU2002332130A1 (en) | Msrebps as modifiers of the srebp pathway and methods of use | |
AU2002357817A8 (en) | Klcs as modifiers of the p53 pathway and methods of use | |
AU2003213693A8 (en) | Mchks as modifiers of the chk pathway and methods of use | |
AU2003213665A8 (en) | Lgals as modifiers of the chk pathway and methods of use | |
AU2003278811A8 (en) | Ldlrs as modifiers of the p53 pathway and methods of use | |
AU2003215004A8 (en) | Msrebps as modifiers of the srebp pathway and methods of use | |
EP1633852A4 (en) | Sppls as modifiers of the p53 pathway and methods of use | |
AU2002345486A1 (en) | Slc13as as modifiers of the p53 pathway and methods of use | |
AU2002312283A1 (en) | Srpks as modifiers of the p53 pathway and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |